The focus of the topic is TBI, neuroinflammation, epilepsy and cognitive decline, however, blocking HMGB1 might achieves significant neuroprotection in several forms of neurodegenerative disorders where neuroinflammation plays a crucial role. This evidence concerns the gene HMGB1 and epilepsy.